Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Baricitinib for the Treatment of Alopecia Areata.
Drugs. 2023 Jun;83(9):761-770. doi: 10.1007/s40265-023-01873-w. Epub 2023 May 17.
Drugs. 2023.
PMID: 37195491
Free PMC article.
Review.
In both studies, the most common adverse events were upper respiratory tract infections, urinary tract infection, acne, headache, and elevated creatine kinase levels. ...
In both studies, the most common adverse events were upper respiratory tract infections, urinary tract infection, acne, …
Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management.
Dierkes J, Westphal S, Luley C.
Dierkes J, et al.
Drug Saf. 2003;26(2):81-91. doi: 10.2165/00002018-200326020-00002.
Drug Saf. 2003.
PMID: 12534325
Review.
Recently, a number of studies have shown an elevation of homocysteine levels with fenofibrate or bezafibrate therapy. Homocysteine is an atherogenic amino acid derived from the methionine cycle. At present, the underlying mechanism for this elevation h …
Recently, a number of studies have shown an elevation of homocysteine levels with fenofibrate or bezafibrate therapy. H …
Item in Clipboard
Cite
Cite